搜索优化
English
搜索
Copilot
图片
视频
地图
资讯
购物
更多
航班
旅游
酒店
笔记本
Top stories
Sports
U.S.
Local
World
Science
Technology
Entertainment
Business
More
Politics
时间不限
过去 1 小时
过去 24 小时
过去 7 天
过去 30 天
按相关度排序
按时间排序
2 天
on MSN
Scientists uncover how cancer cells hijack T-cells, making it harder for the body to fight back
Research led by the Chiba Cancer Center Research Institute in Japan has discovered a surprising way cancer evades the immune ...
Nature
5 天
Cancer cells ‘poison’ the immune system with tainted mitochondria
The malfunctioning mitochondria seem to poison the immune cells, explains Yosuke Togashi, a pulmonary physician and ...
12 天
Eterna Therapeutics Announces Positive Preclinical Study Results on Lead Product ERNA-101 ...
New data from proof-of-concept study provides roadmap for treatment of ovarian cancerCAMBRIDGE, Mass., Jan. 14, 2025 (GLOBE ...
13 天
REVEAL GENOMICS® Links Immune Tumor Response to Longevity in Breast Cancer Survivors
REVEAL GENOMICS, S.L., a Barcelona-based biotechnology start-up seeking to revolutionize precision oncology through biomarker ...
13 天
on MSN
Three drug cocktail shows potential to boost CAR-T cancer therapy
UNC Lineberger Comprehensive Cancer Center researchers have discovered a three-drug combination that enhances the generation ...
AZoNano on MSN
2 天
Local Neoadjuvant Immunotherapy Shows Promise
An injectable hydrogel platform shows promise in local immunotherapy for triple-negative breast cancer, enhancing treatment ...
4 天
on MSN
Injectable supramolecular hydrogel shows promise for neoadjuvant immunotherapy of triple ...
The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of ...
News Medical on MSN
13 天
New drug cocktail enhances CAR-T cells for cancer treatment
Preclinical research findings from the University of North Carolina Lineberger Comprehensive Cancer Center identified a cocktail of three different drugs that can be used to generate more robust ...
12 天
Eterna Announces Positive Preclinical Study Results On ERNA-101 In Ovarian Cancer; Stock Up 69%
Eterna Therapeutics, Inc. (ERNA) announced Tuesday positive results from a preclinical study on the company's lead cell therapy ...
Armed robbery in Revesby
4 天
New Injectable Hydrogel Targets Triple-Negative Breast Cancer
The efficacy of immunotherapy against triple-negative breast cancer (TNBC) heavily relies on intratumoral infiltration of cytotoxic T lymphocytes ...
一些您可能无法访问的结果已被隐去。
显示无法访问的结果
反馈